Abstract – Publication

Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis.
LAGO, Eloi M.; SILVA, Marcos P.; QUEIROZ, Talita G.; MAZLOUM, Susana F.; RODRIGUES, Vinícius C.; CARNAÚBA, Paulo U.; PINTO, Pedro L.; ROCHA, Jefferson A.; FERREIRA, Leonardo G.; ANDRICOPULO, Adriano Defini; MORAES, Josué de.
Abstract: Background: Treatment and control of schistosomiasis, one of the most insidious and serious parasitic diseases, depend almost entirely on a single drug, praziquantel. Since the funding for drug development for povertyassociated diseases is very limited, drug repurposing is a promising strategy. In this study, 73 nonsteroidal anti-inflammatory drugs (NSAIDs) commonly used in medical and veterinary fields were evaluated for their anti-schistosomal properties. Methods: The efficacy of NSAIDs was first tested against adult Schistosoma mansoni ex vivo using phenotypic screening strategy, effective drugs were further tested in a murine model of schistosomiasis. The disease parameters measured were worm and egg burden, hepato- and splenomegaly. Findings: From 73 NSAIDs, five (mefenamic acid, tolfenamic acid, meclofenamic acid, celecoxib, and diclofenac) were identified to effectively kill schistosomes. These results were further supported by scanning electron microscopy analysis. In addition, the octanol-water partition coefficient, both for neutral and ionized species, revealed to be a critical property for the ex vivo activity profile. Compounds were then tested in vivo using both patent and a prepatent S. mansoni infection in a mouse model. The most effective NSAID was mefenamic acid, which highly reduced worm burden, egg production, and hepato- and splenomegaly. Interpretation: The treatment regimen used in this study is within the range for which mefenamic acid has been used in clinical practice, thus, it is demonstrated the capacity of mefenamic acid to act as a potent antischistosomal agent suitable for clinical repurposing in the treatment of schistosomiasis.
EBioMedicine
v. 43, p. 370-379 - Ano: 2019
Fator de Impacto: 6,680
http://dx.doi.org/10.1016/j.ebiom.2019.04.029
    @article={002948112,author = {LAGO, Eloi M.; SILVA, Marcos P.; QUEIROZ, Talita G.; MAZLOUM, Susana F.; RODRIGUES, Vinícius C.; CARNAÚBA, Paulo U.; PINTO, Pedro L.; ROCHA, Jefferson A.; FERREIRA, Leonardo G.; ANDRICOPULO, Adriano Defini; MORAES, Josué de.},title={Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis},journal={EBioMedicine},note={v. 43, p. 370-379},year={2019}}

Contact us
São Carlos Institute of Physics - IFSC
Thank you for the message! We´ll be in touch as soon as possible..